Chia-Ling Chang Selected Research

Fatigue

1/2020

Respiratory Muscle Training Improves Functional Outcomes and Reduces Fatigue in Patients with Myasthenia Gravis: A Single-Center Hospital-Based Prospective Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chia-Ling Chang Research Topics

Disease

5	Infections 11/2023 - 12/2015
4	Neoplasms (Cancer) 11/2023 - 03/2012
3	Chronic Hepatitis B 01/2023 - 01/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 09/2023
2	Hepatitis B 01/2019 - 01/2019
2	Organophosphate Poisoning 12/2015 - 11/2015
2	End Stage Liver Disease 08/2011 - 08/2009
1	Skin Neoplasms (Skin Cancer) 11/2023
1	Venous Thromboembolism 12/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2022
1	Stroke (Strokes) 01/2022
1	Cough 01/2022
1	Gout 01/2021
1	Hyperuricemia 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Pancreatitis 11/2020
1	Knee Osteoarthritis 08/2020
1	Fatigue 01/2020
1	Myasthenia Gravis 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Cross Infection (Nosocomial Infection) 12/2015
1	Sepsis (Septicemia) 12/2015
1	Body Weight Changes 01/2015
1	Obesity 01/2015
1	Breast Neoplasms (Breast Cancer) 09/2013
1	Leukemia 05/2013
1	Liver Diseases (Liver Disease) 03/2012
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2011
1	Carcinogenesis 10/2011
1	Atherosclerosis 10/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2011
1	Adenocarcinoma of Lung 04/2010
1	Neuroblastoma 06/2009

Drug/Important Bio-Agent (IBA)

3	Hepatitis B e AntigensIBA 01/2023 - 01/2019
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 12/2015 - 09/2011
2	guselkumabIBA 11/2023 - 09/2023
2	Immunoglobulin A (IgA)IBA 11/2023 - 09/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2019
1	omega-Chloroacetophenone (Mace)IBA 11/2023
1	Monoclonal AntibodiesIBA 11/2023
1	Interleukin-23 (Interleukin 23)IBA 11/2023
1	Prostaglandins AIBA 09/2023
1	Adalimumab (Humira)FDA Link 09/2023
1	HLA-G Antigens (HLA G)IBA 01/2023
1	HLA-B Antigens (HLA-B)IBA 01/2023
1	RivaroxabanIBA 12/2022
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 03/2022
1	Uric Acid (Urate)IBA 01/2021
1	CarbimazoleIBA 11/2020
1	Methimazole (Thiamazole)FDA LinkGeneric 11/2020
1	Propylthiouracil FDA Link 11/2020
1	Acetylcysteine (Siran)FDA LinkGeneric 08/2020
1	Surface Antigens (Surface Antigen)IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	LipidsIBA 01/2015
1	Anthocyanins (Anthocyanin)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 09/2013
1	Zoledronic Acid (Zometa)FDA Link 09/2013
1	CurcuminIBA 05/2013
1	ResveratrolIBA 10/2011
1	Death Domain ReceptorsIBA 10/2011
1	CCAAT-Enhancer-Binding Protein-alphaIBA 09/2011
1	Adenosine Triphosphatases (ATPase)IBA 04/2010
1	Adenosine Triphosphate (ATP)IBA 06/2009
1	Purinergic P2X7 ReceptorsIBA 06/2009
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2009

Therapy/Procedure

3	Liver Transplantation 03/2012 - 08/2009
2	Therapeutics 01/2022 - 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 11/2020
1	Breathing Exercises 01/2020
1	Operative Surgical Procedures 12/2015